Amphastar Pharmaceuticals (AMPH) Net Margin Growth (1y) (2014 - 2026)
Amphastar Pharmaceuticals (AMPH) Net Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -2,064.00 |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -195.00 |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 376.00 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -303.00 |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | -58.00 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 306.00 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 949.26 Mn | 659.13 Mn | 93.47 Mn | -129.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -129.00 |
| Mar 31, 2026 | -1,108.00 |
| Dec 31, 2025 | 563.00 |
| Sep 30, 2025 | -1,210.00 |
| Jun 30, 2025 | -302.00 |
| Mar 31, 2025 | -1,063.00 |
| Dec 31, 2024 | 10,191.00 |
| Sep 30, 2024 | -633.00 |
| Jun 30, 2024 | 267.00 |
| Mar 31, 2024 | 631.00 |
| Dec 31, 2023 | -10,671.00 |
| Sep 30, 2023 | 1,413.00 |
| Jun 30, 2023 | 388.00 |
| Mar 31, 2023 | -158.00 |
| Dec 31, 2022 | 864.00 |
| Sep 30, 2022 | -1,424.00 |
| Jun 30, 2022 | 577.00 |
| Mar 31, 2022 | 1,689.00 |
| Dec 31, 2021 | 2,256.00 |
| Sep 30, 2021 | 2,185.00 |